drugset
drugset / Trial / NCT01025544

Study in Toddlers (12-18 Months) Comparing a Booster Dose of Vaxem Hib and Hiberix Vaccines for the Prevention of Haemophilus Influenzae Type b Infections in China

NCT01025544 ↗

Phase 3 Completed 846 enrolled Novartis Vaccines
Non-randomizedParallel-groupOpen-labelPrevention

Summary

This study will evaluate the safety and immunogenicity of booster doses of the two vaccines used to prevent Haemophilus influenzae type b infections in children 12-18 months of age.

Timeline

Start
2009-09
Primary completion
2009-12
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN Vaccine — —
Comparator Vaxem Hib Vaccine — —

Indications

haemophilus infectious disease